Asahi Life Asset Management CO. LTD. Invests $307,000 in DaVita Inc. (NYSE:DVA)

Asahi Life Asset Management CO. LTD. bought a new position in DaVita Inc. (NYSE:DVA - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund bought 2,050 shares of the company's stock, valued at approximately $307,000.

A number of other large investors have also added to or reduced their stakes in the stock. Transcendent Capital Group LLC purchased a new stake in shares of DaVita during the 3rd quarter valued at about $25,000. Quarry LP purchased a new stake in shares of DaVita in the third quarter valued at $60,000. Venturi Wealth Management LLC lifted its holdings in shares of DaVita by 59.8% in the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company's stock worth $61,000 after acquiring an additional 152 shares during the last quarter. Versant Capital Management Inc boosted its stake in shares of DaVita by 58.7% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company's stock worth $68,000 after purchasing an additional 169 shares during the period. Finally, Blue Trust Inc. grew its holdings in DaVita by 39.7% during the 4th quarter. Blue Trust Inc. now owns 461 shares of the company's stock valued at $76,000 after purchasing an additional 131 shares during the last quarter. Institutional investors own 90.12% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the stock. Sanford C. Bernstein set a $184.00 target price on shares of DaVita in a research note on Friday, February 21st. Cowen restated a "hold" rating on shares of DaVita in a research note on Tuesday, February 18th. Finally, Barclays lifted their price target on shares of DaVita from $164.00 to $169.00 and gave the company an "equal weight" rating in a research note on Tuesday, February 18th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $166.33.

Remove Ads

DaVita Price Performance

Shares of DVA stock traded down $0.29 during trading hours on Thursday, reaching $139.71. The company had a trading volume of 456,778 shares, compared to its average volume of 785,288. The company has a market capitalization of $11.18 billion, a price-to-earnings ratio of 12.99, a PEG ratio of 1.07 and a beta of 0.99. DaVita Inc. has a 12-month low of $125.64 and a 12-month high of $179.60. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26. The stock has a fifty day moving average of $160.19 and a 200-day moving average of $158.12.

DaVita (NYSE:DVA - Get Free Report) last released its quarterly earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. On average, equities analysts anticipate that DaVita Inc. will post 10.76 earnings per share for the current year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.